Building a Better HIV Drug: Nano-Formulated Medicines

Building a Better HIV Drug: Nano-Formulated Medicines

1 of 7
Next >

Antiretrovirals have turned HIV infection from a deadly disease into a manageable chronic condition. However, current treatment does have downsides, including the need for daily dosing (at minimum) and the risk for drug resistance to emerge when doses are missed.

Antiretrovirals have turned HIV infection from a deadly disease into a manageable chronic condition. However, current treatment does have downsides, including the need for daily dosing (at minimum) and the risk for drug resistance to emerge when doses are missed.

One of the keys to the future of HIV treatment may be nano-formulations of drugs that help deliver medications in a more potent and efficient manner with a lower frequency of doses. Andrew Owen, Ph.D., from the University of Liverpool, gave a mini-lecture at EACS 2013 providing an overview and update on the topic.